2Chu S Y,Callaghan W M,Kim S Y,et al. Maternal obesity and risk of ges- tational diabetes mellitus [ J ]. Diabetes Care,2007,30 ( 8 ) :2070 - 2076.
3Youn BS, Yu KY, Park HJ, et al. Plasma resistin concentrations measured by enzyme - linked immunosorbent assay using a newly devel - monoclonal antibody are elevated in individuals with type 2 dia - betes mellitus [ J 1. J Clin Endocrinol Meta6,2004,891,89 (I) : 150 - 156.
6Coustan DR,Lowe LP, Metzger BE.The Hyperglycemia and Adverse Pregnancy Outcome (HAPO)study: paving the way for new diagnostic criteria for gestational diabetes mellitus[J].Am J Obstet Gynecol, 2010,202(6) : 654.
7Anderberg E, Kall6n K, Berntorp K.The impact of gesta- tional diabetes mellitus on pregnancy outcome comparing different cut-off criteria for abnormal glucose tolerance[J]. Acta Obstet Gynecol Scand,2010,89(12):1532-1537.
8Zawiejska A,Wender-Ozegowska E,Brazert J.Microvascular complications are associated with low levels of maternal sEselectin and sVCAM-1 in pregnancy complicated with pregestational diabetes mellitus [J].Diabetes Research and Clinical Practice,2010,88(02): 164-170.
9Kato R,Munkhjargal M,Takahashi, D, et al.An autonomous drug release system based on chemo-mechanical energy conversion "Organic Engine" for feedback control of blood glucose [J].Biosensors & Bioelectronics: The International Journal for the Professional Involved with Research, Technology and Applications of Biosensers and Related Devices,2010,26(4): 1455-1459.
